Tagged: Bacterial Proteins

Michael Hornsby, PhD


My research focuses on the development of technology and processes used to generate high quality recombinant antibody reagents to disease-relevant protein targets.

Brian Shoichet, PhD


Our lab develops new methods for drug discovery, adopting two strategies to do so. On the one hand, we reduce biology to its molecular components, and seek to change how these fit together using synthetic molecules we design. On the other hand, we investigate how the biological molecules operate together, both in health and disease. Both processes involve intensive modeling and close collaboration between theory and experiment.